Inhibition of the expression of mitogen-activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells.

The Journal of Biological Chemistry
Y L GuoJ R Williamson

Abstract

Previously we showed that rat mesangial cells are normally resistant to tumor necrosis factor-alpha (TNF-alpha)-induced apoptosis. They are made susceptible to the apoptotic effect of TNF-alpha when pretreated with actinomycin D, cycloheximide or vanadate. A sustained c-Jun N-terminal protein kinase (JNK) activation was closely correlated with the initiation of apoptosis under these conditions. We proposed that a TNF-alpha-inducible phosphatase was responsible for preventing a sustained activation of JNK and consequent apoptosis in these cells (Guo, Y.-L., Baysal, K., Kang, B. , Yang, L.-J., and Williamson, J. R. (1998) J. Biol. Chem. 273, 4027-4034). In the present study we provide further evidence to support this hypothesis. Ro318220, although originally identified as a specific inhibitor of protein kinase C, was subsequently found to be a strong inhibitor of MKP-1 expression. In rat mesangial cells, pretreatment of the cells with Ro318220 blocked expression of MKP-1 induced by TNF-alpha. This treatment also prolonged JNK activation and caused apoptosis. Taken together, our results support the currently controversial hypothesis that the JNK pathway is involved in TNF-alpha-induced apoptosis. In addition, we provide a mechanis...Continue Reading

References

Jul 1, 1978·Kidney International·J I KreisbergM J Karnovsky
Nov 24, 1995·Science·Z XiaM E Greenberg
Jul 14, 1995·The Journal of Biological Chemistry·M Karin
Mar 16, 1995·Biochimica Et Biophysica Acta·S M Keyse
Sep 1, 1993·The Biochemical Journal·S E WilkinsonJ S Nixon
Jul 1, 1996·The Journal of Cell Biology·S GrimmK Schulze-Osthoff
Nov 1, 1996·Science·D J Van AntwerpI M Verma
Feb 7, 1997·Cell·S Nagata
Feb 1, 1997·Current Biology : CB·V R Baichwal, P A Baeuerle

❮ Previous
Next ❯

Citations

Aug 6, 2008·Apoptosis : an International Journal on Programmed Cell Death·Simona SeriniGabriella Calviello
Aug 2, 2003·Molecular Aspects of Medicine·Yogesh C AwasthiSanjay Awasthi
Aug 7, 2003·Current Opinion in Pharmacology·Andrew R Clark, Marina Lasa
Sep 21, 2000·Kidney International. Supplement·H MakinoN Kashihara
May 18, 2007·American Journal of Respiratory Cell and Molecular Biology·Linda A Tephly, A Brent Carter
Aug 3, 2006·Journal of Periodontology·Jeanne M NervinaSotirios Tetradis
Oct 12, 2000·Biochemical and Biophysical Research Communications·T HöfkenA C Wagner
Jul 31, 2013·Blood Cells, Molecules & Diseases·Wei DuQishen Pang
Apr 28, 2000·Gastroenterology·F SchliessD Häussinger
Aug 14, 2001·Journal of Cellular Biochemistry·Y L GuoJ R Williamson
Mar 26, 2003·Cell Death and Differentiation·H WajantP Scheurich
Nov 23, 2005·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Mohammad Lornejad-SchaferFreimut Schliess
Feb 27, 2008·The FEBS Journal·Rafael Pulido, Rob Hooft van Huijsduijnen
Aug 29, 2012·The British Journal of Dermatology·R B KjellerupL Iversen
Jun 11, 1999·Immunology and Cell Biology·A J ButtR C Baxter
Apr 17, 2003·Endocrinology·Francesca GalbiatiAlberto M Davalli
Nov 2, 2014·International Journal of Cancer. Journal International Du Cancer·Marco Lo IaconoGiorgio Vittorio Scagliotti

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis